Scoping review examines connections between autism spectrum conditions and eating disorder presentations in clinical settings
Photo by Peter Burdon / Unsplash
Key Takeaway
Autism and eating disorders are linked, particularly for conditions not involving low body weight, requiring specialized support and early identification.
This scoping review investigates the intersection of autism and eating disorders within clinical populations. Longitudinal evidence indicates that autistic traits observed in childhood may influence later presentations, yet no direct association was found between body mass index and autistic traits. This distinction is crucial for understanding the underlying mechanisms of these co-occurring conditions.
The analysis reveals that eating disorders linked to autism often differ from those associated with low body weight. Furthermore, the study clarifies that the relationship between autism and eating disorders persists independently of acute illness effects. This suggests a deeper, more complex interplay between neurodevelopmental factors and disordered eating behaviors.
High rates of additional mental health problems do not fully account for the co-occurrence of autism or autistic traits in individuals with eating disorders. Future research should expand beyond anorexia nervosa to include other eating disorder populations. Improved training and autism-specific support are essential for mental health services to better serve these individuals.
More on Autism
Umbrella review of 134 reviews links autism with elevated risks for multiple adverse outcomes including anxiety and suicidality
Autistic people face higher risks for mental health issues and daily life challenges
This umbrella review synthesizes 134 existing reviews to examine outcomes in autistic people. The authors report elevated risks for a broad …
A review of 134 studies shows autistic individuals often face higher risks for anxiety, mood problems, and self-harm. They also struggle mor…
Meta-analysis of nonpharmacological interventions for young autistic children finds limited moderation by cognitive or language scores
Language and cognitive scores do not predict intervention effects for young autistic children
This meta-analysis of nonpharmacological interventions for young autistic children synthesized 1,911 effect sizes. It found no significant m…
A large review of studies found that a child's language or thinking skills did not predict how well non-drug therapies worked for autism. Ho…
Observational study finds Touch Activated Phlebotomy reduces pain in autistic and non-autistic adults compared to traditional venipuncture
Touch Activated Phlebotomy Causes Less Pain Than Traditional Blood Draws
This primary research article reports on an observational study of 23 participants, including 11 autistic adults and 12 non-autistic adults.
A small study found a new blood draw device caused less pain than standard methods for both autistic and non-autistic adults.
Qualitative review highlights barriers to recognizing autism in women with borderline personality disorder diagnoses
Many women with BPD may actually be autistic
This qualitative review synthesizes interviews with 15 clinicians and 15 women or people assigned female at birth regarding autism recogniti…
Hundreds of women told doctors they were misdiagnosed with borderline personality disorder when they may actually be autistic, raising urgen…
View Original Abstract ↓
ObjectiveResearch has highlighted co-occurrence and phenotypic overlap between autism and eating disorders (EDs), however the origin of this overlap is uncertain. The aim of this scoping review was to assess existing evidence on the role of acute illness effects and co-occurring mental health difficulties in the relationship between autism and EDs.MethodsThe review was conducted following the PRISMA extension for scoping reviews. Electronic databases (PsycINFO, PubMed, Embase and Web of Science) and grey literature (ProQuest Dissertation and Theses) were searched up until 11th January 2026 for quantitative, qualitative, and mixed-methods empirical studies using autism and ED search terms.ResultsLongitudinal and qualitative evidence reporting Autistic traits in childhood, a lack of association between BMI and Autistic traits, and a link between autism and EDs not typically associated with low body weight suggests that the association between autism and EDs is not solely due to acute illness effects. High rates of additional mental health problems in those with EDs were not found to fully account for co-occurring autism or Autistic traits.DiscussionAreas for further research include ED populations other than anorexia nervosa (AN), and EDs in Autistic individuals rather than trait-based research. The review highlights the need for early identification of autism and support for Autistic young people, as well as improved training and autism-specific support in ED and other mental health services.Systematic review registrationOpen Science Framework, https://osf.io/t5fwg.
PETRUSHKA decision-support tool reduced treatment discontinuation and improved symptoms in major depressive disorder
The Algorithm That Helps Doctors Pick the Right Antidepressant for You
Related in Psychiatry
Guideline proposes design principles for technology to reduce child sexual abuse material viewing
A New App Helps People Stop Viewing Harmful Images
This guideline synthesizes qualitative findings from at-risk individuals and service providers in four European countries. It proposes seven…
A new app design helps people stop viewing harmful images by giving them full control over their own privacy and safety features.
Case report details vitamin B12 treatment for nitrous oxide induced neurological damage
Nitrous oxide linked to lasting brain fog and nerve damage
This case report describes a patient with protracted encephalopathy associated with nitrous oxide use who received vitamin B12 supplementati…
Chronic nitrous oxide use can cause lasting brain fog and nerve damage, and a new case report shows vitamin B12 may help but long-term plans…
Meta-analysis shows intermittent fasting lowers BMI and fasting glucose in women with overweight or obesity
Intermittent Fasting Works for Weight Loss But Has a Catch
This meta-analysis pooled data from 1287 participants to evaluate intermittent fasting in women with overweight or obesity. The analysis fou…
For women struggling with weight, intermittent fasting twice a week may lower body mass index and blood sugar, but don't expect it to fix yo…
Systematic review and meta-analysis links intolerance of uncertainty to depression in children and adolescents
Kids' Fear of the Unknown Fuels Depression More Than We Thought
This systematic review and meta-analysis examined the association between intolerance of uncertainty and depression in children and adolesce…
• Fear of uncertainty strongly links to teen depression symptoms • Helps parents spot hidden emotional struggles early • Better child-specif…
From Other Specialties
Systematic review and meta-analysis compares Rome III and Rome IV criteria for functional abdominal pain disorder prevalence
New Rome IV rules show fewer people have functional abdominal pain compared to older guidelines
This systematic review and meta-analysis evaluates the prevalence of functional abdominal pain disorder (FAPD) and its subtypes using Rome I…
A big review found that using newer rules makes it look like fewer people have stomach pain problems. This change happens because the new ch…
FDA Approves Ziextenzo (pegfilgrastim-bmez) for Febrile Neutropenia and Acute Radiation Syndrome
FDA approves new biosimilar drug Ziextenzo to prevent infections in cancer patients.
The FDA approved Ziextenzo (pegfilgrastim-bmez) to decrease febrile neutropenia in patients with non-myeloid malignancies receiving myelosup…
The FDA approved Ziextenzo, a biosimilar to Neulasta, to prevent infections in cancer patients receiving chemotherapy and to treat radiation…
FDA Approves Wezlana (ustekinumab-ttwe) for Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, and Ulcerative Colitis
FDA approves Wezlana, a biosimilar to Stelara, for several inflammatory conditions.
The FDA approved Wezlana (ustekinumab-ttwe), a biosimilar to Stelara, for moderate to severe plaque psoriasis, active psoriatic arthritis, m…
The FDA approved Wezlana (ustekinumab-ttwe), a biosimilar to Stelara, for plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcera…
FDA Approves Wezlana (ustekinumab-ttwe) for Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, and Ulcerative Colitis
FDA approves Wezlana, a biosimilar to Stelara, for inflammatory conditions.
The FDA approved Wezlana (ustekinumab-ttwe), a biosimilar to Stelara, for multiple indications including plaque psoriasis, psoriatic arthrit…
The FDA approved Wezlana, a biosimilar to Stelara, for plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. It of…